| 상품명칭 |
(S)-란소프라졸 |
| 별명 |
1H-벤지미다졸, 2-[(S)-[[3-메틸-4-(2,2,2-트리플루오로에톡시)-2-피리디닐]메틸]설피닐]-(9CI); 1H-벤지미다졸, 2-3-메틸-4-(2,2,2-트리플루오로에톡시)-2-피리디닐]메틸]설피닐]-, (S)-; 레볼란소프라졸; 2-[(S)-[[3-메틸-4-(2,2,2-트리플루오로에톡시)-2-피리디닐]메틸]설피닐]-1H-벤즈이미다졸; 2-[(S)-{[3-메틸-4-(2,2,2-트리플루오로에톡시)피리딘-2-일]메틸}설피닐]-1H-벤즈이미다졸 |
| 영문 이름 |
(S)-Lansoprazole;1H-Benzimidazole, 2-[(S)-[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]- (9CI); 1H-Benzimidazole, 2-[[[3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-, (S)-; Levolansoprazole; 2-[(S)-[[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridinyl]methyl]sulfinyl]-1H-benzimidazole; 2-[(S)-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl]methyl}sulfinyl]-1H-benzimidazole |
| 분자식 |
C16H14F3N3O2S |
| 분자량 |
369.3615 |
| InChI |
InChI=1/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)/t25-/m0/s1 |
| cas번호 |
138530-95-7 |
| 분자 구조 |
|
| 밀도 |
1.502g/cm3 |
| 비등점 |
555.791°C at 760 mmHg |
| 굴절 지수 |
1.635 |
| 인화점 |
289.932°C |
| 증기압 |
0mmHg at 25°C |
| 위험성 표시 |
|
| 리스크 규칙 |
|
| 보안 규칙 |
|
|
